
Capital Group Buy: Digital Pathology

Epredia
Epredia is a global company specializing in precision cancer diagnostics and tissue diagnostics, providing solutions and technologies for pathology labs. They aim to improve patient outcomes by enhancing cancer diagnostics through their products and services.
Group Buy Details
- Premier Contract: PP-LA-618
- Contract Category: Digital Pathology Systems, Accessories and Services
- Start Date:
- End Date:
- Take delivery date: August 30, 2025